Liying Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liying Zhu has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Chengcheng Li
School of Public Health, Guizhou Medical University, Guiyang, Guizhou 561113, PR China; Guizhou Prenatal Diagnosis Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China
6 shared publicationsHaizhi Li
Reproductive Centre, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China
3 shared publicationsNenghong Yang
Affiliated Hospital of Guizhou Medical University Guizhou Medical University Guiyang China
3 shared publications- Wei Pan
Department of Medical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
3 shared publications - Wei Pan
Prenatal Diagnosis Center in Guizhou Province, The Affiliated Hospital of Guizhou Medical University, Guizhou, Guiyang, China
3 shared publications - Xing Li
Department of Medical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
3 shared publications
Latest Publications
- Open Access
- 28 March 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 314, 120058
Network toxicology and machine learning revealed the association between non-alcoholic fatty liver disease induced by polystyrene nanoplastics
- 28 March 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 314, 120058
Open AccessNetwork toxicology and machine learning revealed the association between non-alcoholic fatty liver disease induced by polystyrene nanoplastics
- Open Access
- 19 December 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (12)
Glycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications
Emerging evidence indicates a critical link between diabetic complications and the interplay of glycemic variability and gut microbiota metabolic activity. This review comprehensively examines the regulatory effects of glycemic fluctuations on the composition and function of the gut microbiota, while elucidating the key mechanisms by which microbial metabolic reprogramming—mediated through short‐chain fatty acids, bile acids, and other metabolites—disrupts host metabolic and immune homeostasis, thereby exacerbating diabetic complications. Research demonstrates that glycemic variability not only directly contributes to vascular and neuronal damage but also remodels the gut microbiota's metabolic network, triggering systemic metabolic dysregulation and chronic low‐grade inflammation. Building on these findings, we explore novel therapeutic strategies targeting the gut microbiota for the prevention and management of diabetic complications. By adopting a “gut‐organ axis” framework, this study unveils the cascade of interactions among glycemic variability, gut microbiota, and metabolic disturbances in the pathogenesis of diabetic complications, offering both theoretical foundations and innovative approaches for clinical intervention.
- 19 December 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (12)
Open AccessGlycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications
Emerging evidence indicates a critical link between diabetic complications and the interplay of glycemic variability and gut microbiota metabolic activity. This review comprehensively examines the regulatory effects of glycemic fluctuations on the composition and function of the gut microbiota, while elucidating the key mechanisms by which microbial metabolic reprogramming—mediated through short‐chain fatty acids, bile acids, and other metabolites—disrupts host metabolic and immune homeostasis, thereby exacerbating diabetic complications. Research demonstrates that glycemic variability not only directly contributes to vascular and neuronal damage but also remodels the gut microbiota's metabolic network, triggering systemic metabolic dysregulation and chronic low‐grade inflammation. Building on these findings, we explore novel therapeutic strategies targeting the gut microbiota for the prevention and management of diabetic complications. By adopting a “gut‐organ axis” framework, this study unveils the cascade of interactions among glycemic variability, gut microbiota, and metabolic disturbances in the pathogenesis of diabetic complications, offering both theoretical foundations and innovative approaches for clinical intervention.
- Open Access
- 24 September 2025
- Published by Elsevier in Translational Oncology
- Vol. 62, 102542
Near-infrared spectroscopy of blood plasma amino acids with chemometrics towards breast cancer discrimination
- 24 September 2025
- Published by Elsevier in Translational Oncology
- Vol. 62, 102542
Open AccessNear-infrared spectroscopy of blood plasma amino acids with chemometrics towards breast cancer discrimination
- Open Access
- 1 January 2023
- Published by Wiley in International Journal of Intelligent Systems
- Vol. 2023 (1)
Application of Serum Mid‐Infrared Spectroscopy Combined with Machine Learning in Rapid Screening of Breast Cancer and Lung Cancer
Cancer is an increasing burden on global health. Breast and lung cancers are the two tumors with the highest incidence rates. The study shows that early detection and early diagnosis are important prognostic factors for breast and lung cancers. Due to the great advantages of artificial intelligence in feature extraction, the combination of infrared analysis technology may have great potential in clinical applications. This study explores the potential application of mid‐infrared spectroscopy combined with machine learning for the differentiation of breast and lung cancers. The experiment collects blood samples from clinical sources, separates serum, trains classification models, and finally predicts unknown sample categories. We use k‐fold cross‐validation to determine the training set of 301 cases and the test set of 50 cases. Through differential spectrum analysis, we found that the intervals of 1318.59–1401.03 cm−1, 1492.15–1583.27 cm−1, and 1597.25–1721.64 cm−1 have significant differences, which may reflect the absorption of key chemical bonds in protein molecules. We use a total of 24 models such as decision trees, discriminant analysis, support vector machines, and K‐nearest neighbor to train, identify, and distinguish spectra. The results show that under the same conditions, the prediction model trained based on fine KNN has the best performance and can perform 100% prediction on the test set samples. This also shows that our model has important potential for auxiliary diagnosis of serum breast cancer and lung cancer. This method may help to further achieve comprehensive screening of associated cancers in underserved areas, thereby reducing the cancer burden through early detection of cancer and appropriate treatment and care of cancer patients.
- 1 January 2023
- Published by Wiley in International Journal of Intelligent Systems
- Vol. 2023 (1)
Open AccessApplication of Serum Mid‐Infrared Spectroscopy Combined with Machine Learning in Rapid Screening of Breast Cancer and Lung Cancer
Cancer is an increasing burden on global health. Breast and lung cancers are the two tumors with the highest incidence rates. The study shows that early detection and early diagnosis are important prognostic factors for breast and lung cancers. Due to the great advantages of artificial intelligence in feature extraction, the combination of infrared analysis technology may have great potential in clinical applications. This study explores the potential application of mid‐infrared spectroscopy combined with machine learning for the differentiation of breast and lung cancers. The experiment collects blood samples from clinical sources, separates serum, trains classification models, and finally predicts unknown sample categories. We use k‐fold cross‐validation to determine the training set of 301 cases and the test set of 50 cases. Through differential spectrum analysis, we found that the intervals of 1318.59–1401.03 cm−1, 1492.15–1583.27 cm−1, and 1597.25–1721.64 cm−1 have significant differences, which may reflect the absorption of key chemical bonds in protein molecules. We use a total of 24 models such as decision trees, discriminant analysis, support vector machines, and K‐nearest neighbor to train, identify, and distinguish spectra. The results show that under the same conditions, the prediction model trained based on fine KNN has the best performance and can perform 100% prediction on the test set samples. This also shows that our model has important potential for auxiliary diagnosis of serum breast cancer and lung cancer. This method may help to further achieve comprehensive screening of associated cancers in underserved areas, thereby reducing the cancer burden through early detection of cancer and appropriate treatment and care of cancer patients.
- Open Access
- 9 March 2020
- Published by Wiley in Cell Biochemistry and Function
- Vol. 38 (5) , 621-629
Transcription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most frequent cause of cancer‐related death. The IRX5 transcription factor plays a different role in multiple cancers and contributes to the development of many tumours. However, little is known about the molecular mechanisms of IRX5 in HCC. In this study, we found that IRX5 was abnormally upregulated in HCC tissues compared with adjacent normal tissues. IRX5 promoted HCC cell proliferation and upregulated the expression of cyclin D1 and knockdown of IRX5 suppressed tumorigenicity in vivo. Furthermore, knockdown of IRX5 increased p53 and Bax expression and decreased Bcl‐2 expression. Thus, IRX5 suppressed apoptosis in HCC cells by inhibiting the p53 signalling pathway, indicating its role as a treatment target for HCC.Significance of the study: Our study demonstrated that IRX5 was abnormally upregulated in HCC tissues compared with adjacent normal tissues. IRX5 promoted HCC cell proliferation and upregulated the expression of cyclin D1, and knockdown of IRX5 suppressed tumorigenicity in vivo. Furthermore, knockdown of IRX5 increased p53 and Bax expression and decreased Bcl‐2 expression. IRX5 suppressed apoptosis in HCC cells by inhibiting the p53 signalling pathway, indicating its role as a treatment target for HCC.
- 9 March 2020
- Published by Wiley in Cell Biochemistry and Function
- Vol. 38 (5) , 621-629
Open AccessTranscription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most frequent cause of cancer‐related death. The IRX5 transcription factor plays a different role in multiple cancers and contributes to the development of many tumours. However, little is known about the molecular mechanisms of IRX5 in HCC. In this study, we found that IRX5 was abnormally upregulated in HCC tissues compared with adjacent normal tissues. IRX5 promoted HCC cell proliferation and upregulated the expression of cyclin D1 and knockdown of IRX5 suppressed tumorigenicity in vivo. Furthermore, knockdown of IRX5 increased p53 and Bax expression and decreased Bcl‐2 expression. Thus, IRX5 suppressed apoptosis in HCC cells by inhibiting the p53 signalling pathway, indicating its role as a treatment target for HCC.Significance of the study: Our study demonstrated that IRX5 was abnormally upregulated in HCC tissues compared with adjacent normal tissues. IRX5 promoted HCC cell proliferation and upregulated the expression of cyclin D1, and knockdown of IRX5 suppressed tumorigenicity in vivo. Furthermore, knockdown of IRX5 increased p53 and Bax expression and decreased Bcl‐2 expression. IRX5 suppressed apoptosis in HCC cells by inhibiting the p53 signalling pathway, indicating its role as a treatment target for HCC.
- Open Access
- 14 November 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 1156-1164
LncRNA CRNDE promotes the epithelial‐mesenchymal transition of hepatocellular carcinoma cells via enhancing the Wnt/β‐catenin signaling pathway
Colorectal neoplasia differentially expressed (CRNDE) is a significantly upregulated long noncoding RNA in hepatocellular carcinoma (HCC). CRNDE could promote cell proliferation, migration, and invasion, while its molecular mechanisms were still largely unclear. In this study, we investigated the expression and function of CRNDE. CRNDE was significantly upregulated in tumor tissues compared with adjacent normal tissues. In vitro, we revealed that knockdown of CRNDE inhibited cell proliferation, migration, and cell invasion capacities in HCC. Animal studies indicated that CRNDE knockdown represses both growth and metastasis of HCC tumors in vivo. Moreover, knockdown of CRNDE suppressed the cell epithelial‐mesenchymal transition (EMT) process by increasing the expression of E‐cadherin and ZO‐1, whereas, decreasing the expression of N‐cadherin, slug, twist, and vimentin in HCC cells. We also revealed that knockdown of CRNDE suppressed the Wnt/β‐catenin signaling in HCC. Thus, CRNDE could modulate EMT of HCC cells and knockdown of CRNDE impaired the mesenchymal properties. CRNDE increased invasion of HCC cells might be through activating the Wnt/β‐catenin signaling pathway.
- 14 November 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 1156-1164
Open AccessLncRNA CRNDE promotes the epithelial‐mesenchymal transition of hepatocellular carcinoma cells via enhancing the Wnt/β‐catenin signaling pathway
Colorectal neoplasia differentially expressed (CRNDE) is a significantly upregulated long noncoding RNA in hepatocellular carcinoma (HCC). CRNDE could promote cell proliferation, migration, and invasion, while its molecular mechanisms were still largely unclear. In this study, we investigated the expression and function of CRNDE. CRNDE was significantly upregulated in tumor tissues compared with adjacent normal tissues. In vitro, we revealed that knockdown of CRNDE inhibited cell proliferation, migration, and cell invasion capacities in HCC. Animal studies indicated that CRNDE knockdown represses both growth and metastasis of HCC tumors in vivo. Moreover, knockdown of CRNDE suppressed the cell epithelial‐mesenchymal transition (EMT) process by increasing the expression of E‐cadherin and ZO‐1, whereas, decreasing the expression of N‐cadherin, slug, twist, and vimentin in HCC cells. We also revealed that knockdown of CRNDE suppressed the Wnt/β‐catenin signaling in HCC. Thus, CRNDE could modulate EMT of HCC cells and knockdown of CRNDE impaired the mesenchymal properties. CRNDE increased invasion of HCC cells might be through activating the Wnt/β‐catenin signaling pathway.
- Open Access
- 22 October 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 1997-2006
Long noncoding RNA NEAT1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma through interacting with miR‐384
It was reported that long non‐coding RNA nuclear‐enriched abundant transcript 1 (NEAT1) is involved in hepatocellular carcinoma (HCC). However, the underlying mechanism of tumorigenesis is still largely unclear. Here, we found that NEAT1 is remarkably upregulated in HCC tissues and cell lines. Overexpression of NEAT1 notably accelerated HCC cell proliferation, migration, and invasion. Knockdown of NEAT1 significantly inhibited HCC cell proliferation, migration and invasion. MiR‐384 expression was lower in HCC tissues and cell lines than adjacent nontumor tissues and L02 cell. MiR‐384 exhibited the functions of tumor‐suppressive. The expression of miR‐384 was negatively correlated with the expression of NEAT1. Overexpression of NEAT1 reduced miR‐384 expression, whereas inhibition of miR‐384 led to a distinct upregulation of NEAT1 expression. In addition, we provided evidence that miR‐384 was directly bound to the sequence of NEAT1 by luciferase reporter and RNA‐binding protein immunoprecipitation assays. Overexpression of miR‐384 inhibited NEAT1 function. Thus, we demonstrated that NEAT1 promotes the malignant biological properties of hepatocellular carcinoma by negatively regulating miR‐384.
- 22 October 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 1997-2006
Open AccessLong noncoding RNA NEAT1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma through interacting with miR‐384
It was reported that long non‐coding RNA nuclear‐enriched abundant transcript 1 (NEAT1) is involved in hepatocellular carcinoma (HCC). However, the underlying mechanism of tumorigenesis is still largely unclear. Here, we found that NEAT1 is remarkably upregulated in HCC tissues and cell lines. Overexpression of NEAT1 notably accelerated HCC cell proliferation, migration, and invasion. Knockdown of NEAT1 significantly inhibited HCC cell proliferation, migration and invasion. MiR‐384 expression was lower in HCC tissues and cell lines than adjacent nontumor tissues and L02 cell. MiR‐384 exhibited the functions of tumor‐suppressive. The expression of miR‐384 was negatively correlated with the expression of NEAT1. Overexpression of NEAT1 reduced miR‐384 expression, whereas inhibition of miR‐384 led to a distinct upregulation of NEAT1 expression. In addition, we provided evidence that miR‐384 was directly bound to the sequence of NEAT1 by luciferase reporter and RNA‐binding protein immunoprecipitation assays. Overexpression of miR‐384 inhibited NEAT1 function. Thus, we demonstrated that NEAT1 promotes the malignant biological properties of hepatocellular carcinoma by negatively regulating miR‐384.
- RetractedOpen Access
- 3 September 2018
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 37 (1) , 1-16
RETRACTED ARTICLE: Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression
Background: Emerging evidences have indicated that long noncoding RNAs (lncRNAs) play essential roles in the development and progression of cancers. Dysregulation of lncRNA MIR31HG has recently been reported in several types of cancers, and researches on the function of MIR31HG in cancers suggested that MIR31HG could act as either oncogene or tumor suppressor. But the functional involvement of MIR31HG has not been studied in hepatocellular carcinoma (HCC). Methods: In this study, MTS assays, colony formation assay, Wound-healing assay, Transwell assy, and tumor xenografts experiments were used to identify biological effects of MIR31HG on HCC cells HCC proliferation and metastasis in vitro and in vivo. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were performed to show the interactions of MIR31HG and miR-575. The bioinformatics methods were completed to find the target genes of miR-575. And Dual-luciferase reporter assay and Western blot analysis were further used to confirm the target gene of miR-575. Results: We found that overexpression of MIR31HG obviously suppressed HCC proliferation and metastasis in vitro and in vivo, whereas knockdown of MIR31HG had the opposite effects. Besides, overexpression of MIR31HG significantly decreased the expression of microRNA-575 (miR-575), which plays an oncogenic role in HCC. Moreover, dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay revealed that MIR31HG exerted tumor-suppressive functions by binding directly to miR-575, and there was a reciprocal inhibition between MIR31HG and miR-575 in the same RNA-induced silencing complex (RISC). Furthermore, overexpression of MIR31HG enhanced the expression of suppression of tumorigenicity 7 like (ST7L), which was identified as a downstream target gene of miR-575. Thus, MIR31HG positively regulated ST7L expression through sponging miR-575, and acted as tumor suppressor in HCC. Conclusions: Overall, our study illuminates the role of MIR31HG as a miRNA sponge in HCC, and sheds new light on lncRNA-directed diagnostics and therapeutics in HCC.
- 3 September 2018
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 37 (1) , 1-16
RetractedOpen AccessRETRACTED ARTICLE: Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression
Background: Emerging evidences have indicated that long noncoding RNAs (lncRNAs) play essential roles in the development and progression of cancers. Dysregulation of lncRNA MIR31HG has recently been reported in several types of cancers, and researches on the function of MIR31HG in cancers suggested that MIR31HG could act as either oncogene or tumor suppressor. But the functional involvement of MIR31HG has not been studied in hepatocellular carcinoma (HCC). Methods: In this study, MTS assays, colony formation assay, Wound-healing assay, Transwell assy, and tumor xenografts experiments were used to identify biological effects of MIR31HG on HCC cells HCC proliferation and metastasis in vitro and in vivo. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were performed to show the interactions of MIR31HG and miR-575. The bioinformatics methods were completed to find the target genes of miR-575. And Dual-luciferase reporter assay and Western blot analysis were further used to confirm the target gene of miR-575. Results: We found that overexpression of MIR31HG obviously suppressed HCC proliferation and metastasis in vitro and in vivo, whereas knockdown of MIR31HG had the opposite effects. Besides, overexpression of MIR31HG significantly decreased the expression of microRNA-575 (miR-575), which plays an oncogenic role in HCC. Moreover, dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay revealed that MIR31HG exerted tumor-suppressive functions by binding directly to miR-575, and there was a reciprocal inhibition between MIR31HG and miR-575 in the same RNA-induced silencing complex (RISC). Furthermore, overexpression of MIR31HG enhanced the expression of suppression of tumorigenicity 7 like (ST7L), which was identified as a downstream target gene of miR-575. Thus, MIR31HG positively regulated ST7L expression through sponging miR-575, and acted as tumor suppressor in HCC. Conclusions: Overall, our study illuminates the role of MIR31HG as a miRNA sponge in HCC, and sheds new light on lncRNA-directed diagnostics and therapeutics in HCC.